Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat for Nonintubated ARDS Due to Pathogen-Associated Lung Injury
NCT07086755Phase 3Recruiting
- Start
- Oct 2025
- Primary completion
- May 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vadadustat in acute respiratory distress syndrome (ARDS). Started Oct 2025; status: recruiting.
02
Drugs
vadadustat
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07086755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07086755.